Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis

J Thromb Thrombolysis. 2021 Apr;51(3):830-832. doi: 10.1007/s11239-020-02253-x. Epub 2020 Aug 20.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • COVID-19 / complications
  • COVID-19 / drug therapy*
  • Heparin / therapeutic use*
  • Humans
  • Thromboembolism / prevention & control*
  • Thromboembolism / virology

Substances

  • Anticoagulants
  • Heparin

Supplementary concepts

  • COVID-19 drug treatment